Surgery Unit, Casa di Cura San Pio X, Via Francesco Nava, 31, 20159, Milan, Italy.
Int J Colorectal Dis. 2010 Dec;25(12):1487-93. doi: 10.1007/s00384-010-0957-y. Epub 2010 Jun 17.
This prospective, two-centre study was designed to evaluate long-term outcomes when using a collagen plug to treat cryptoglandular anal fistulae.
Over 3 years, 60 consecutive patients with cryptoglandular fistulae were treated using an anal fistula plug by experienced surgeons. Preoperative, postoperative and follow-up data were collected in a dedicated database. Success was defined as the closure of all fistula openings and the absence of discharge. Faecal incontinence scores were administered at baseline and at 6 months follow-up.
Eleven patients had multiple fistula tracts. All fistulae treated in this series were classified as complex. Seventeen fistulae were anterior tracts in females, and the remaining tracts were trans-sphincteric in nature. Thirty-eight tracts were recurrent. Mean operative time was 26 ± 10 min. No major complications, active sepsis or mortality were observed. Success rate with a mean follow-up of 13 months was 60% of patients and 70% of tracts. Mean time for recurrence was 5.7 months. Two recurrent patients were successfully treated with a redo plug procedure, and five were successfully closed with a post-plug fistulotomy, leading to a global 72% success rate without continence impairment. Of the patients with a minimum follow-up of 6 months (mean, 18.5 months; range, 6-34 months), 29 in 32 (90.6%) were healed at final evaluation. In these patients, the mean preoperative CCF incontinence score was 0.73. This was reduced to 0.14 at 6-month follow-up. The mean reduction of CCF incontinence score was -0.6 (95% CI, 1.3 to -0.1; p = 0.01).
Fistula tract treatment with the anal fistula plug is a safe and viable surgical option that should be offered to complex fistula patients. The reasons and risk factors for recurrence remain to be explored.
本前瞻性、双中心研究旨在评估使用胶原塞治疗隐匿性肛腺肛瘘的长期疗效。
在 3 年期间,由经验丰富的外科医生使用肛门瘘管塞治疗 60 例连续隐匿性肛腺瘘患者。收集术前、术后和随访数据,并录入专门的数据库。成功定义为所有瘘管开口闭合且无分泌物。在基线和 6 个月随访时进行粪便失禁评分。
11 例患者存在多个瘘管。本研究中治疗的所有瘘管均被归类为复杂性。女性瘘管 17 例为前位,其余瘘管为经括约肌性。38 例为复发性瘘管。平均手术时间为 26±10 分钟。未观察到主要并发症、活动性脓毒症或死亡。平均随访 13 个月时,60%的患者和 70%的瘘管成功。复发的平均时间为 5.7 个月。2 例复发性患者通过再次使用塞栓治疗成功,5 例通过塞栓后瘘管切开术成功闭合,总成功率为 72%,且无失禁损害。在至少随访 6 个月(平均随访 18.5 个月,范围 6-34 个月)的患者中,32 例中有 29 例(90.6%)在最终评估时痊愈。这些患者术前 CCF 失禁评分平均为 0.73,随访 6 个月时降至 0.14。CCF 失禁评分平均降低 0.6(95%CI,1.3 至-0.1;p=0.01)。
使用肛门瘘管塞治疗瘘管是一种安全可行的手术选择,应向复杂性瘘管患者提供。复发的原因和危险因素仍有待探讨。